Home>Topics>Stocks>PDL BioPharma

PDL BioPharma PDLI

  1. All
  2. Commentary
  3. Headlines
    1. Healthcare Dogs Stay Steady In April

      Headlines

      Thu, 24 May 2012

      By Fredrik Arnold : This monthly report series began applying dog dividend methodology to each of eight major market sectors in December. The sectors were, in alphabetical order: basic materials; consumer goods; financial; healthcare; industrial goods; services; technology; utilities. A ninth ...

    2. 9 Rallying Biotech Stocks Being Snapped Up By Hedge Funds

      Headlines

      Tue, 15 May 2012

      By Kapitall : Interested in the growth prospects of the biotech industry? For a closer look at stocks of the biotech sector with positive market sentiment, we ran a screen. We began by screening the biotech industry for stocks currently rallying above their 20-day, 50-day, and 200-day moving ...

    3. Making Retirement Work Without a Huge Nest Egg

      Headlines

      Mon, 14 May 2012

      LUTHP) 1,630 0.37 N/A Roth: Norfolk Southern NSC 3,316 0.76 Roth: Paychex PAYX 956 0.22 Roth: PDL BioPharma PDLI 1,394 0.32 N/A Roth: Procter & Gamble PG 1,668 0.38 Roth: Prospect Capital PSEC 1,456 0.33 N/A

    4. These 5 Big Healthcare Stocks Have Major Upside In 2013

      Headlines

      Fri, 4 May 2012

      By ValueMax : In recent years, Abbott Laboratories ( ABT ) has been everything a buy-and-hold investor might want. In the past 10 years, its earnings have increased an average of 8% and book value has increased an average of 10%. It has raised its dividend every year. In fact, the dividend has gone

    5. PDL BioPharma ( PDLI ): Q1 EPS of $0.29 beats by $0.02. Revenue of $77.3M (-7.2% Y/Y) in-line. (PR)

      Headlines

      Thu, 3 May 2012

      PDL BioPharma ( PDLI ): Q1 EPS of $0.29 beats by $0.02 . Revenue of $77.3M (-7.2% Y/Y) in-line. ( PR ) Post your comment!

    6. PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript

      Headlines

      Thu, 3 May 2012

      PDL BioPharma , Inc. ( PDLI ) Q1 2012 Earnings Call May 3, 2012 4:30 p.m. ET Executives ..... Capital Markets Presentation Operator Good afternoon and welcome to PDL BioPharma ’s First Quarter 2012 Earnings Conference Call. Today’s call

    7. 9 Undervalued Healthcare Stocks Being Snapped Up By Hedge Funds

      Headlines

      Sun, 29 Apr 2012

      By Kapitall : Do you like to follow the buying trends of smart money investors like hedge fund managers? For a closer look at stocks that the smart money is buying up, we ran a screen. We began by screening the healthcare sector for stocks that appear undervalued relative to earnings growth, with

    8. Healthcare Dogs Sit And Stay In March

      Headlines

      Fri, 13 Apr 2012

      By Fredrik Arnold : This monthly report series began applying dog dividend methodology to each of eight major market sectors in December. The sectors were, in alphabetical order: basic materials; consumer goods; financial; healthcare; industrial goods; services; technology; utilities. A ninth ...

    9. 7 Reasons To Pick Up This Unusual 9% Yielder

      Headlines

      Mon, 2 Apr 2012

      a 9% plus dividend looks intriguing here. PDL BioPharma ( PDLI ) - " PDL BioPharma , Inc. engages in the management of antibody ..... description from Yahoo Finance ) 7 reasons PDL BioPharma is a great pick up for just over $6 a share

    10. 9 Undervalued Healthcare Stocks With Strong Hedge Fund Buying

      Headlines

      Sat, 31 Mar 2012

      By Kapitall : The healthcare sector is generally known as a growth sector, especially because it includes industries such as biotech. However the sector is diverse and also includes mega-cap drug companies and health insurance providers as well. These industries contribute to healthcare's defensive

    « Prev12345Next »
    Content Partners